Edition:
United Kingdom

Biofrontera AG (B8FGn.DE)

B8FGn.DE on Xetra

5.60EUR
4:36pm BST
Change (% chg)

€-0.17 (-2.95%)
Prev Close
€5.77
Open
€5.76
Day's High
€5.76
Day's Low
€5.44
Volume
90,073
Avg. Vol
171,548
52-wk High
€7.63
52-wk Low
€2.91

Latest Key Developments (Source: Significant Developments)

Biofrontera Q1 Sales Revenues Between EUR 4.6-4.7 Mln
Thursday, 12 Apr 2018 

April 12 (Reuters) - Biofrontera AG ::ADHOC: BIOFRONTERA AG: BIOFRONTERA ANNOUNCES PRELIMINARY UNAUDITED SALES REVENUES FOR THE 1ST QUARTER 2018.REVENUES OF BIOFRONTERA GROUP FOR PERIOD JANUARY TO MARCH 2018 WERE BETWEEN 4.6 AND 4.7 MILLION EUROS.  Full Article

Deutsche Balaton: Voluntary Acquisition Offer For Shares Of Biofrontera
Friday, 16 Mar 2018 

March 19 (Reuters) - Deutsche Balaton AG ::SAID ON FRIDAY DEUTSCHE BALATON TO BID FOR BIOFRONTERA AG <<>>.TO SUBMIT A VOLUNTARY PURCHASE OFFER FOR UP TO 6.25 MLN SHARES OF BIOFRONTERA AG, WHICH CORRESPONDS TO ABOUT 14% OF THE CURRENTLY ISSUED SHARES OF BIOFRONTERA AG.DOES NOT PLAN TO BUY CONTROLLING STAKE.AIM OF THE ACQUISITION OFFER IS TO EXCEED THE BLOCKING THRESHOLD OF 25% BY THE JOINTLY ACTING SHAREHOLDERS DELPHI UNTERNEHMENSBERATUNGS AG AND DEUTSCHE BALATON AG.CONSIDERATION OFFERED FOR THE BIOFRONTERA SHARES EXPECTED TO BE COMPOSED OF A TRADABLE FINANCIAL INSTRUMENT AND NOMINAL CASH PAYMENT PER SHARE.  Full Article

Biofrontera: European Commission Approves Use Of Ameluz In Combination With Daylight Photodynamic Therapy
Monday, 5 Mar 2018 

March 5 (Reuters) - Biofrontera AG ::PTA-ADHOC: BIOFRONTERA AG: EUROPEAN COMMISSION APPROVES USE OF AMELUZ IN COMBINATION WITH DAYLIGHT PHOTODYNAMIC THERAPY.  Full Article

Biofrontera ADS Open At $13.00 In Debut, About 32 Pct Above IPO Price
Wednesday, 14 Feb 2018 

Feb 14 (Reuters) - :BIOFRONTERA ADS OPEN AT $13.00 IN DEBUT ON THE NASDAQ VERSUS IPO PRICE OF $9.88/ADS.  Full Article

Biofrontera Sets Price For New Shares At 4.00 Euros
Friday, 9 Feb 2018 

Feb 9 (Reuters) - Biofrontera AG ::BIOFRONTERA AG ANNOUNCES SUBSCRIPTION PRICE FOR NEW SHARES.‍SUBSCRIPTION PRICE FOR NEW SHARES WAS SET TODAY AT EUR 4.00​.  Full Article

Biofrontera AG Says Estimate That IPO Price Will Be Between $11 And $13 Per ADS
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - Biofrontera Ag ::BIOFRONTERA AG SAYS ESTIMATE THAT THE INITIAL PUBLIC OFFERING PRICE WILL BE BETWEEN $11.00 AND $13.00 PER ADS – SEC FILING‍​.BIOFRONTERA AG SAYS IT HAD PREVIOUSLY EXPECTED U.S. IPO PRICED BETWEEN $8.80 AND $10.80 PER ADS.  Full Article

Biofrontera Adjusts Expectations With Regard To Subscription Price Of New Shares
Wednesday, 31 Jan 2018 

Jan 31 (Reuters) - BIOFRONTERA AG ::PTA-ADHOC: BIOFRONTERA AG: BIOFRONTERA AG ADJUSTS EXPECTATIONS WITH REGARD TO SUBSCRIPTION PRICE OF NEW SHARES.TO ADJUST RANGE FOR ANTICIPATED SUBSCRIPTION PRICE PER NEW SHARE TO EUR 4.00 UP TO EUR 6.00.TO ADJUST MAXIMUM SUBSCRIPTION PRICE TO EUR 6.00.  Full Article

Biofrontera AG Files For U.S. IPO Of Up To $21.6 Million
Friday, 12 Jan 2018 

Jan 12 (Reuters) - :BIOFRONTERA AG FILES FOR U.S. IPO OF UP TO $21.6 MILLION – SEC FILING.BIOFRONTERA AG - APPLICATION HAS BEEN MADE FOR LISTING OF THE ADS ON THE NASDAQ CAPITAL MARKET UNDER THE SYMBOL “BFRA”.BIOFRONTERA AG SAYS DAWSON JAMES SECURITIES, INC, LAKE STREET CAPITAL MARKETS ARE AMONG UNDERWRITERS TO IPO.  Full Article

Biofrontera Files Investigational New Drug Application
Tuesday, 19 Dec 2017 

Dec 19 (Reuters) - BIOFRONTERA AG ::PTA-NEWS: BIOFRONTERA AG: BIOFRONTERA FILES INVESTIGATIONAL NEW DRUG APPLICATION.BIOFRONTERA - ‍FILES INVESTIGATIONAL NEW DRUG APPLICATION WITH U.S. FDA FOR PHASE III TRIAL OF AMELUZ TO TREAT BASAL CELL CARCINOMA​.  Full Article

Biofrontera 9-Mth ‍Net Loss Widens to EUR 14.6 Mln
Monday, 27 Nov 2017 

Nov 27 (Reuters) - BIOFRONTERA AG ::‍REVENUES INCREASED BY 155% TO EUR7.3 MILLION IN 9MTH, COMPARED TO EUR2.9 MILLION IN SAME PERIOD 2016​.‍NET LOSS WAS EUR14.6 MILLION IN FIRST NINE MONTHS 2017, COMPARED TO EUR7.2 MILLION IN SAME PERIOD 2016​.‍ADJUSTED FULL YEAR 2017 REVENUE ESTIMATES TO EUR12 MILLION​.  Full Article

BRIEF-Deltus 30. AG To Make Offer For Stake In Biofrontera AG

* SAYS TO MAKE OFFER FOR UP TO 6.25 MILLION SHARES IN BIOFRONTERA AG